Financials

  • Market Capitalization 220.29 M
  • Employee 48
  • Founded 2020
  • CEO N/A
  • Website www.evommune.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y79N887
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-1.53
Índice preço/fluxo de caixa
8.08

Related tickers

#NomePreços24h %7d %1M %1A %Capitalização de mercadoÚltimos 7 dias
3451
KROS
Keros Therapeutics, Inc. - common stock
11.61 USD-2.85%+0.43%+4.59%-23.11%230.19 M USD
3469
PLX
Protalix BioTherapeutics, Inc. Common Stock
2.78 USD+0.72%+3.73%+6.11%-4.79%223.99 M USD
3479
STRO
Sutro Biopharma, Inc. - Common Stock
13.28 USD-6.94%-12.29%-22.29%-23.63%220.20 M USD
3494
TRDA
Entrada Therapeutics, Inc. - Common Stock
5.50 USD-3.00%-0.36%-19.12%-21.09%214.15 M USD